The European Medicines Agency (EMA) has opened a new consultation on a draft guideline that would revise a set of biosimilar guidelines first put in place six years ago. The guideline, On non-clinical ...
The European Medicines Agency's (EMA) management board has signed off on the regulator's clinical trials transparency policy, adopting several changes along the way the regulator said would make the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results